financetom
Business
financetom
/
Business
/
Biogen Completes Acquisition of Alcyone Therapeutics
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Biogen Completes Acquisition of Alcyone Therapeutics
Nov 14, 2025 1:35 PM

04:24 PM EST, 11/14/2025 (MT Newswires) -- Biogen (BIIB) on Friday said it completed its acquisition of Alcyone Therapeutics, adding the company's ThecaFlex DRx implantable intrathecal delivery system to support future use with Spinraza, its spinal muscular atrophy treatment.

The device is designed to replace repeat lumbar punctures and is currently being studied in the PIERRE trials.

Biogen said it aims to introduce the system for Spinraza in 2028, subject to trial results and regulatory approvals.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved